Axxcess Wealth Management’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $329K | Hold |
22,834
| – | – | 0.01% | 694 |
|
|
2025
Q1 | $158K | Hold |
22,834
| – | – | ﹤0.01% | 820 |
|
|
2024
Q4 | $121K | Hold |
22,834
| – | – | ﹤0.01% | 837 |
|
|
2024
Q3 | $83.3K | Hold |
22,834
| – | – | ﹤0.01% | 872 |
|
|
2024
Q2 | $62.3K | Hold |
22,834
| – | – | ﹤0.01% | 830 |
|
|
2024
Q1 | $79.5K | Hold |
22,834
| – | – | ﹤0.01% | 851 |
|
|
2023
Q4 | $32.7K | Hold |
22,834
| – | – | ﹤0.01% | 819 |
|
|
2023
Q3 | $33.3K | Hold |
22,834
| – | – | ﹤0.01% | 786 |
|
|
2023
Q2 | $35.8K | Hold |
22,834
| – | – | ﹤0.01% | 579 |
|
|
2023
Q1 | $34.9K | Hold |
22,834
| – | – | ﹤0.01% | 624 |
|
|
2022
Q4 | $38.4K | Hold |
22,834
| – | – | ﹤0.01% | 606 |
|
|
2022
Q3 | $28K | Sell |
22,834
-1,334
| -6% | -$1.64K | ﹤0.01% | 536 |
|
|
2022
Q2 | $40K | Sell |
24,168
-4,000
| -14% | -$6.62K | ﹤0.01% | 526 |
|
|
2022
Q1 | $69K | Hold |
28,168
| – | – | 0.01% | 615 |
|
|
2021
Q4 | $105K | Buy |
+28,168
| New | +$105K | 0.01% | 608 |
|